Assessing Clinical Symptoms and Their Subtypes in The Management of Schizophrenia Spectrum Disorder

Schizophrenia is a mental disorder characterized by disoruption in thought process, perception, emotional responsiveness and social interaction. It is a common illness, with a lifetime prelevance near 1% (2020) approximately 24 million individuals world wide suffer from schizophrenia on the basis of the latest reviews paranoid schizophrenia is the most common type characterized by hallucinations, delusions and irregular thinking of behaviour. The suicidality will increases in this type of schizophrenia. The implications of these findings for developing precision medicine for psychotic symptoms as well as negative and cognitive symptoms used for conventional and atypical antipsychotics. By all the researchers done it will be helpful for the indepth study and diagnosis of the disease.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-11
DOI
https://doi.org/10.5281/zenodo.14396540
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessing Clinical Symptoms and Their Subtypes in The Management of Schizophrenia Spectrum Disorder

Zenodo (CERN European Organization for Nuclear Research)
Schizophrenia research and treatment
article

Assessing Clinical Symptoms and Their Subtypes in The Management of Schizophrenia Spectrum Disorder

article en

Abstract

Schizophrenia is a mental disorder characterized by disoruption in thought process, perception, emotional responsiveness and social interaction. It is a common illness, with a lifetime prelevance near 1% (2020) approximately 24 million individuals world wide suffer from schizophrenia on the basis of the latest reviews paranoid schizophrenia is the most common type characterized by hallucinations, delusions and irregular thinking of behaviour. The suicidality will increases in this type of schizophrenia. The implications of these findings for developing precision medicine for psychotic symptoms as well as negative and cognitive symptoms used for conventional and atypical antipsychotics. By all the researchers done it will be helpful for the indepth study and diagnosis of the disease.

Zenodo (CERN European Organization for Nuclear Research)
Reduced inequalities
Openalex Percentile: Top 57%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.